Loading clinical trials...

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis | Clinical Trials | Clareo Health

COMPLETEDNA

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

NCT01739673•Cxlusa

Summary

This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Subjects must be 18 years of age or older.
•2. Ability to provide written informed consent.
•3. Likely to complete all study visits.
•4. Subjects must have one eye that with a diagnosis of infectious keratitis.

Exclusion Criteria

•1. A corneal perforation.
•2. Descemetocele.
•3. Pregnancy or breastfeeding.
•4. Active Herpes corneal disease.
•5. Patient is unwilling or unable to comply with a medication regimen and follow up appointments.

Locations (6)

Schwartz Laser Eye Center

Scottsdale, Arizona, United States

Davidorf Eye Group

West Hills, California, United States

Corneal Consultants of Colorado, PC

Littleton, Colorado, United States

Center for Excellence in Eye Care

Miami, Florida, United States

Minnesota Eye Consultants

Minneapolis, Minnesota, United States

Ophthalmology Associates

St Louis, Missouri, United States

Key Dates

Start Date

August 1, 2011

Primary Completion Date

July 1, 2014

Completion Date

July 1, 2014

Last Updated

September 26, 2018

Enrollment

ACTUAL participants

Conditions

Infectious Keratitis

Interventions

Ultraviolet-A and riboflavin

OTHER

Microbiological Diagnosis of Infectious Keratitis to Pathogenic Fastidious Germs

NCT02819232

Infectious Keratitis

View study

UNKNOWNNA

Crosslinking in Infectious Keratitis

NCT03801590

Infectious Keratitis

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 26, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions